These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 91819)

  • 41. [The diencephalo-hypophyseo-thyroid axis in essential obesity. Note I. Pituitary TSH response to intravenous TRH].
    Consolo F; Laurà A; Pata P; Giannetto M; Trimarchi F
    Boll Soc Ital Biol Sper; 1975 Dec; 51(24):1908-11. PubMed ID: 821499
    [No Abstract]   [Full Text] [Related]  

  • 42. [T.R.H. test in 93 cases of thyroid disease].
    Murie N; Goasguen J; Almange C; Huguenin A
    Nouv Presse Med; 1975 Nov; 4(37):2635-8. PubMed ID: 812062
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined therapy of T3, and antidepressants in depression.
    Tsutsui S; Yamazaki Y; Namba T; Tsushima M
    J Int Med Res; 1979; 7(2):138-46. PubMed ID: 113269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thyrotropin-releasing hormone: differential antidepressant and endocrinological effects.
    Furlong FW; Brown GM; Beeching MF
    Am J Psychiatry; 1976 Oct; 133(10):1187-90. PubMed ID: 823828
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone.
    Kastin AJ; Ehrensing RH; Schalch DS; Anderson MS
    Lancet; 1972 Oct; 2(7780):740-2. PubMed ID: 4116150
    [No Abstract]   [Full Text] [Related]  

  • 47. Inverse relationship between CSF TRH concentrations and the TSH response to TRH in abstinent alcohol-dependent patients.
    Adinoff B; Nemeroff CB; Bissette G; Martin PR; Linnoila M
    Am J Psychiatry; 1991 Nov; 148(11):1586-8. PubMed ID: 1656797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of anterior pituitary target cells for arginine vasopressin: including cells that store adrenocorticotropin, thyrotropin-beta, and both hormones.
    Childs GV; Westlund KN; Unabia G
    Endocrinology; 1989 Jul; 125(1):554-9. PubMed ID: 2544413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood langerhans cell histiocytosis.
    Maghnie M; Bossi G; Klersy C; Cosi G; Genovese E; Aricò M
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3089-94. PubMed ID: 9745408
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction between triiodothyronine and ovarian steroid hormones on the regulation of the release of thyrotropin and thyrotropin-releasing hormone in vitro.
    Liu SR; Tsai SC; Lu CC; Lee KY; Liu TC; Pu HF; Wang PS
    Chin J Physiol; 1997 Dec; 40(4):221-6. PubMed ID: 9551251
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamics of thyrotropin-releasing hormone-induced thyrotropin and prolactin secretion by acutely dispersed rat adenohypophyseal cells. Evidence for 'all-or-none' secretion by heterogeneous secretory units, each with a specific response threshold.
    Keith LD; Tam B; Ikeda H; Opsahl Z; Greer MA
    Neuroendocrinology; 1986; 43(4):445-52. PubMed ID: 3092122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of growth hormone-releasing peptide-2 for diagnosis of thyrotropin-producing pituitary adenomas.
    Kageyama K; Sakihara S; Kameda W; Sugiyama A; Takayasu S; Terui K; Daimon M
    Endocr J; 2018 Oct; 65(10):1049-1054. PubMed ID: 29973439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TSH responses to TRH in endogenous depression.
    Kirkegaard C; Bjørum N
    Lancet; 1980 Jan; 1(8160):152. PubMed ID: 6101485
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical and CNS effects of oral and I.V. Thyrotropin-releasing hormone in depressed patients.
    Itil TM; Patterson CD; Polvan N; Bigelow A; Bergey B
    Dis Nerv Syst; 1975 Sep; 36(9):529-36. PubMed ID: 809253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abnormal anterior pituitary responsiveness to hypothalamic hormones in depression: neurophysiological correlates and psychopharmacological effects.
    Brambilla F; Pugnetti L; Scarone S; Gambini O; Maggioni M; Nobile P
    Adv Biochem Psychopharmacol; 1985; 40():69-80. PubMed ID: 3927662
    [No Abstract]   [Full Text] [Related]  

  • 56. Alcohol and anterior-pituitary secretion.
    Loosen PT; Prange AJ
    Lancet; 1977 Nov; 2(8045):985. PubMed ID: 72332
    [No Abstract]   [Full Text] [Related]  

  • 57. A double-blind crossover sequential trial of oral thyrotrophin-releasing hormone in depression.
    Mountjoy CQ; Price JS; Weller M; Hunter P; Hall R; Dewar JH
    Lancet; 1974 May; 1(7864):958-60. PubMed ID: 4133645
    [No Abstract]   [Full Text] [Related]  

  • 58. The comparison of thyrotropin releasing hormone, luteinising hormone-releasing hormone and placebo in depressive patients using a double-blind cross-over technique.
    Benkert O; Gordon A; Martschke D
    Psychopharmacologia; 1974; 40(2):191-8. PubMed ID: 4217458
    [No Abstract]   [Full Text] [Related]  

  • 59. Maintenance treatment of endogenous depression.
    Kirkegaard C; Lauridsen UB; Bjorum N
    Lancet; 1976 Sep; 1(7984):525. PubMed ID: 74490
    [No Abstract]   [Full Text] [Related]  

  • 60. Distinguishing depression subtypes by thyrotropin response to TRH testing.
    Amsterdam JD; Winokur A; Mendels J; Snyder P
    Lancet; 1979 Oct; 2(8148):904-5. PubMed ID: 90997
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.